Two compounds, obtained by random screening, and displaying micromolar acti
vities on the At opiate receptor were used as starting points for optimizat
ion. In that work, the traditional concept of the activity of a compound (r
elated to one or a few targets) was extended to the comprehensive pharmacol
ogical profile of that compound on more than 70 receptors, transporters, an
d channels relevant to a CNS-oriented project. Using the two complementary
design strategies based on two similarity concepts described in the previou
s paper, we have obtained analogues with IC50 values ranging between 0.9 nM
and a few micromolar on the mu receptor and displaying qualitatively diffe
rent profiles. We discuss here, both on a case-by-case basis and from a sta
tistical standpoint, the pharmacological profiles in light of the two simil
arity concepts.